Events

Join us as the finalist teams from our 2023 Accelerating BioVenture Innovation (ABI) course pitch their technologies to a panel of early-stage investors and their peers. The judges for this year include:

• James Bellush, PhD'19, RTW Investments
• Lazar Bojic, PhD, Curie.Bio
• Silvia Codony, MBA, NY Ventures, NYS-ESD
• Adam Cotton, PhD, MBA, Novartis Venture Fund
• Matias Porras Paniagua, PhD, Associate, Insight Partners

The pitch event will take place at Uris Auditorium, 1300 York Ave, New York, NY. Following the pitches there will be a networking reception at Griffis Faculty Lounge (same location) with investors, ecosystem partners and industry representatives who served as mentors and lecturers throughout our program. Come celebrate the winning teams and WCM innovation with hors d'oeuvres and cocktails!

Register here. 

Research tools, such as cell lines, rodents, and reagents, are an essential part of exploring our unanswered scientific questions. While often overlooked for commercialization, licensing of research tools has the potential to reduce MTA burden and generate sizable financial returns. But what distinguishes an academic project from a successful commercial product?

Featuring:

• Karen Wu, Ph.D., President and Co-Founder at Lucerna
• James Hoberg, Ph.D., Head of External Innovation & Licensing, Millipore Sigma
• Chuck Na, MSc, Innovation Manager, ATCC
• Peter Wells, MBA, Contracts & Licensing Manager, The Jackson Laboratory
• Iris Bica, Business Development and Licensing Associate, Weill Cornell Medicine (Moderator)

Join the Center for Technology Licensing at Weill Cornell as we convene a panel of industry experts to learn about the research tools industry and the valuable research tools that might be hiding in your freezer. Register here. 

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell and Gene Therapy, Cardiovascular, Immunology, Radiology and Digital Health! Do you have that breakthrough innovation in health care but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

Bayer’s mission is to boost innovation in EMEA and bring it to the patients who need it most. We are looking to enable and support standout innovation in health care by providing cost-free mentorship and knowledge exchange.

Join Bayer's Expert Mondays, dedicated to topics that can support you, your innovation and your startup in its growth! Benefit from Bayer's global expertise, network with fellow founders and the Bayer Pharma team, and ask your questions.
 
Please note: These sessions are not intended for service providers, consultants, IT providers, etc., but are limited to drug developers and researchers in health care who are seeking collaboration with big pharma and out-licensing opportunities later in their journey.

Please note that recordings will not be sent to those who did not attend live.

This workshop is part of a virtual series presented by the Center for Regional Economic Advancement, a division of the Office of the Vice President for Research and Innovation at Cornell University. Designed to explore the entrepreneurial journey from ideation to operation, the series is open to anyone with a vision for a startup, including researchers, faculty, doctoral students, graduate students and undergraduates across Cornell’s campuses.

Join us to learn what to consider when choosing an accelerator or incubator. Questions? Contact crea@cornell.edu.

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell and Gene Therapy, Cardiovascular, Immunology, Radiology and Digital Health! Do you have that breakthrough innovation in health care but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

Bayer’s mission is to boost innovation in EMEA and bring it to the patients who need it most. We are looking to enable and support standout innovation in health care by providing cost-free mentorship and knowledge exchange.

Join Bayer's Expert Mondays, dedicated to topics that can support you, your innovation and your startup in its growth! Benefit from Bayer's global expertise, network with fellow founders and the Bayer Pharma team, and ask your questions.
 
Please note: These sessions are not intended for service providers, consultants, IT providers, etc., but are limited to drug developers and researchers in health care who are seeking collaboration with big pharma and out-licensing opportunities later in their journey.

Please note that recordings will not be sent to those who did not attend live.

The Daedalus Fund for Innovation is a unique initiative designed to advance early-stage applied and translational research projects that have clear, relatively near-term commercial potential. The core objective is to create resources to bridge the funding gap and accelerate research projects to the point at which they would be considered "partnership ready" with a goal of building a robust data validation package and generating (or strengthening) solid intellectual property positions to attract investment and commercialization partners from industry and the venture community.

What You Need to Know:

• Two categories of funding: Level I – funding of up to $200k for 1 year and Level II – funding of up to $200k per year for a period of 2 years
• Use the funding to advance inventions toward licensing, startup creation, or industry partnerships
• Open to Weill Cornell Medicine researchers with disclosed, active inventions that have been disclosed to Center for Technology Licensing at Weill Cornell

Pre-proposals are currently being accepted until November 27, 2023. Please submit applications to DaedalusFund@med.cornell.edu.

Successful applicants will be informed by mid-December 2023 and invited to submit full proposals for review by the Daedalus Fund’s independent external Scientific Advisory Committee.

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell and Gene Therapy, Cardiovascular, Immunology, Radiology and Digital Health! Do you have that breakthrough innovation in health care but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

Bayer’s mission is to boost innovation in EMEA and bring it to the patients who need it most. We are looking to enable and support standout innovation in health care by providing cost-free mentorship and knowledge exchange.

Join Bayer's Expert Mondays, dedicated to topics that can support you, your innovation and your startup in its growth! Benefit from Bayer's global expertise, network with fellow founders and the Bayer Pharma team, and ask your questions.
 
Please note: These sessions are not intended for service providers, consultants, IT providers, etc., but are limited to drug developers and researchers in health care who are seeking collaboration with big pharma and out-licensing opportunities later in their journey.

Please note that recordings will not be sent to those who did not attend live.

This workshop is part of a virtual series presented by the Center for Regional Economic Advancement, a division of the Office of the Vice President for Research and Innovation at Cornell University. Designed to explore the entrepreneurial journey from ideation to operation, the series is open to anyone with a vision for a startup, including researchers, faculty, doctoral students, graduate students and undergraduates across Cornell’s campuses.

Join us to learn how to attract investors. Questions? Contact crea@cornell.edu.

Entrepreneurship at Cornell hosts an annual summit in New York City featuring speakers who are inspiring, entrepreneurial role models. Don’t miss your chance to listen to amazing speakers, network with fellow Cornellians, students and business executives, and watch some of Cornell’s awesome startups pitch their businesses. During the networking breaks, participants will have a chance to meet and mingle with approximately 450 enthusiastic attendees including faculty and alumni – many of whom are active entrepreneurs, venture capitalists and angel investors.

STEM researchers: ready to explore the commercialization potential of your deep technology innovation? I-Corps can provide you with entrepreneurial education, mentoring, and up to $50,000 in funding for customer discovery. 

Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session on Tuesday, October 24 (12:00 – 12:45 p.m. ET) will cover all the benefits of I-Corps regional and national programming, with a particular focus on hybrid-format course opportunities tailored to specific industries. Designed for busy graduate students, postdocs, and faculty, the session will also feature I-Corps alumni and instructors sharing their experiences and answering your questions.

The National Science Foundation created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products, and processes with the potential to benefit society. 

Register: https://bit.ly/ICorpsInfoOct23